199 related articles for article (PubMed ID: 26369955)
21. Immobilization-Enhanced Eradication of Bacterial Biofilms and in situ Antimicrobial Coating of Implant Material Surface - an in vitro Study.
Tran HA; Tran PA
Int J Nanomedicine; 2019; 14():9351-9360. PubMed ID: 31819436
[TBL] [Abstract][Full Text] [Related]
22. A chlorhexidine-releasing epoxy-based coating on titanium implants prevents Staphylococcus aureus experimental biomaterial-associated infection.
Riool M; Dirks AJ; Jaspers V; de Boer L; Loontjens TJ; van der Loos CM; Florquin S; Apachitei I; Rijk LN; Keul HA; Zaat SA
Eur Cell Mater; 2017 Feb; 33():143-157. PubMed ID: 28197990
[TBL] [Abstract][Full Text] [Related]
23. Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated, hospital-acquired bacterial infections.
Gwisai T; Hollingsworth NR; Cowles S; Tharmalingam N; Mylonakis E; Fuchs BB; Shukla A
Biomed Mater; 2017 Jul; 12(4):045010. PubMed ID: 28471351
[TBL] [Abstract][Full Text] [Related]
24. Significant Suppression of
Zhang B; Braun BM; Skelly JD; Ayers DC; Song J
ACS Appl Mater Interfaces; 2019 Aug; 11(32):28641-28647. PubMed ID: 31313901
[TBL] [Abstract][Full Text] [Related]
25. Effect of vancomycin-coated tympanostomy tubes on methicillin-resistant Staphylococcus aureus biofilm formation: in vitro study.
Jang CH; Park H; Cho YB; Choi CH
J Laryngol Otol; 2010 Jun; 124(6):594-8. PubMed ID: 20056010
[TBL] [Abstract][Full Text] [Related]
26. Staphylococcus aureus resistance on titanium coated with multivalent PEGylated-peptides.
Khoo X; O'Toole GA; Nair SA; Snyder BD; Kenan DJ; Grinstaff MW
Biomaterials; 2010 Dec; 31(35):9285-92. PubMed ID: 20863561
[TBL] [Abstract][Full Text] [Related]
27. Biofilm-based implant infections in orthopaedics.
Arciola CR; Campoccia D; Ehrlich GD; Montanaro L
Adv Exp Med Biol; 2015; 830():29-46. PubMed ID: 25366219
[TBL] [Abstract][Full Text] [Related]
28. Tannic acid inhibits Staphylococcus aureus surface colonization in an IsaA-dependent manner.
Payne DE; Martin NR; Parzych KR; Rickard AH; Underwood A; Boles BR
Infect Immun; 2013 Feb; 81(2):496-504. PubMed ID: 23208606
[TBL] [Abstract][Full Text] [Related]
29. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
30. Bioactive Functional Nanolayers of Chitosan-Lysine Surfactant with Single- and Mixed-Protein-Repellent and Antibiofilm Properties for Medical Implants.
Ajdnik U; Zemljič LF; Plohl O; Pérez L; Trček J; Bračič M; Mohan T
ACS Appl Mater Interfaces; 2021 May; 13(20):23352-23368. PubMed ID: 33998809
[TBL] [Abstract][Full Text] [Related]
31. Surfactin effectively inhibits Staphylococcus aureus adhesion and biofilm formation on surfaces.
Liu J; Li W; Zhu X; Zhao H; Lu Y; Zhang C; Lu Z
Appl Microbiol Biotechnol; 2019 Jun; 103(11):4565-4574. PubMed ID: 31011774
[TBL] [Abstract][Full Text] [Related]
32. The giant staphylococcal protein Embp facilitates colonization of surfaces through Velcro-like attachment to fibrillated fibronectin.
Khan N; Aslan H; Büttner H; Rohde H; Golbek TW; Roeters SJ; Woutersen S; Weidner T; Meyer RL
Elife; 2022 Jul; 11():. PubMed ID: 35796649
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo comparisons of staphylococcal biofilm formation on a cross-linked poly(ethylene glycol)-based polymer coating.
Saldarriaga Fernández IC; Mei HC; Metzger S; Grainger DW; Engelsman AF; Nejadnik MR; Busscher HJ
Acta Biomater; 2010 Mar; 6(3):1119-24. PubMed ID: 19733265
[TBL] [Abstract][Full Text] [Related]
34. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
Giacometti A; Cirioni O; Gov Y; Ghiselli R; Del Prete MS; Mocchegiani F; Saba V; Orlando F; Scalise G; Balaban N; Dell'Acqua G
Antimicrob Agents Chemother; 2003 Jun; 47(6):1979-83. PubMed ID: 12760879
[TBL] [Abstract][Full Text] [Related]
35. A Simultaneously Antimicrobial, Protein-Repellent, and Cell-Compatible Polyzwitterion Network.
Kurowska M; Eickenscheidt A; Guevara-Solarte DL; Widyaya VT; Marx F; Al-Ahmad A; Lienkamp K
Biomacromolecules; 2017 Apr; 18(4):1373-1386. PubMed ID: 28269987
[TBL] [Abstract][Full Text] [Related]
36. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus.
Cassat JE; Lee CY; Smeltzer MS
Methods Mol Biol; 2007; 391():127-44. PubMed ID: 18025674
[TBL] [Abstract][Full Text] [Related]
37. Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents.
Hogan S; O'Gara JP; O'Neill E
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203484
[TBL] [Abstract][Full Text] [Related]
38. Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance In Vitro.
Cardile AP; Sanchez CJ; Samberg ME; Romano DR; Hardy SK; Wenke JC; Murray CK; Akers KS
BMC Res Notes; 2014 Jul; 7():457. PubMed ID: 25034276
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
40. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors.
Nishitani K; Sutipornpalangkul W; de Mesy Bentley KL; Varrone JJ; Bello-Irizarry SN; Ito H; Matsuda S; Kates SL; Daiss JL; Schwarz EM
J Orthop Res; 2015 Sep; 33(9):1311-9. PubMed ID: 25820925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
